(Q28180054)

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Efficacy of sulphadoxine-pyrimethamine for acute uncomplicated malaria due to Plasmodium falciparum in Malawian children under five years old.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

1 reference

7 January 2021

Drug development for neglected diseases: a deficient market and a public-health policy failure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Comparison of bednets impregnated with different pyrethroids for their impact on mosquitoes and on re-infection with malaria after clearance of pre-existing infections with chlorproguanil-dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

Antimalarial drug resistance and combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900547-4

7 January 2021

10.1016/S1473-3099(03)00547-4

Identifiers

DOI

0 references

Fatcat ID

release_neagtcvqynhc3j5l7bkrasy3su

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/neagtcvqynhc3j5l7bkrasy3su

24 November 2022